. advertisement .china's plans to import indian drugs fail to enthuse indian pharmaceutical firms . .hide comments . . cambridge's bluebird bio licenses delivery tech to novartis, gsk .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. .: "fremanezumab for the preventive treatment of chronic migraine." http://lm360.us/Mares-daughter-of-Matsumoto-from-Eichenberg?Loreesist=115 . alleging abuse, family of blac chyna's ailing assistant plan to sue . .